With the analysis among 1,761 patents, we discovered top 203 key players by total patent application. Oncolytics Biotech, Inc., Oncorus, Inc., Transgene Biopharmaceutical Technology (Shanghai) Co. Ltd. are dominant in this area. They take 14.08% of the total patent filing.
Alberta, Canada
Patent: 119
Massachusetts, United States
Patent: 73
Transgene Biopharmaceutical Technology (Shanghai) Co. Ltd.
Shanghai Shi, China
Patent: 56
Texas, United States
Patent: 51
Ohio State Innovation Foundation
Ohio, United States
Patent: 48
California, United States
Patent: 47
Guangzhou Virotech Pharmaceutical Co., Ltd.
Guangdong Sheng, China
Patent: 37
German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ)
With the analysis among 127 patents, we discovered top 19 start-ups by total patent application. Biosion, Inc., Kalivir Immunotherapeutics, Shenzhen Immvira Pharma Co., Ltd. are active in this area.
Jiangsu Sheng, China
Patent: 25
Kalivir Immunotherapeutics
Pennsylvania, United States
Patent: 19
Shenzhen Immvira Pharma Co., Ltd.
Guangdong Sheng, China
Patent: 12
Calidi Biotherapeutics, Inc.
California, United States
Patent: 11
Arizona, United States
Patent: 11
Minnesota, United States
Patent: 7
Turnstone Biologics, Inc.
California, United States
Patent: 6
Institut National de la Santé et de la Recherche Médicale
With the analysis among related 1,322 patents applied in the last 5 years. We discover 243 most active companies in this area. The fast-growing Oncorus, Inc., Amgen, Inc., Univ of Pittsburgh take 10.29% of patent filing during this period.
Massachusetts, United States
Patent: 51
California, United States
Patent: 47
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 35
Ohio State Innovation Foundation
Ohio, United States
Patent: 30
Arizona, United States
Patent: 29
Beijing Mabworks Biotech Co., Ltd.
Beijing Shi, China
Patent: 29
Gyeonggi-do, South Korea
Patent: 28
Jiangsu Sheng, China
Patent: 25
California, United States
Patent: 23
With the analysis among related 1,322 patents in last 5 years, we discover 166 new entrants. Amgen, Inc., Boehringer Ingelheim International GmbH, Arizona State University are the most active new entrants in this area.
California, United States
Patent: 47
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 35
Arizona, United States
Patent: 29
Beijing Mabworks Biotech Co., Ltd.
Beijing Shi, China
Patent: 29
Jiangsu Sheng, China
Patent: 25
California, United States
Patent: 23
Shanghai Joint Biosciences Ltd.
Shanghai Shi, China
Patent: 20
Kalivir Immunotherapeutics
Pennsylvania, United States
Patent: 19
California, United States
Patent: 16
With the analysis among 621 patents, we discovered top 68 universities and scientific research institutions by total patent application. Ruprecht-Karls-Universität Heidelberg, Baylor College of Medicine, Arizona State University are dominant in this area. They take 19.16% of the total patent filing.
Ruprecht-Karls-Universität Heidelberg
Baden-Württemberg, Germany
Patent: 31
Baylor College of Medicine
Texas, United States
Patent: 31
Arizona, United States
Patent: 29
Ontario, Canada
Patent: 15
Massachusetts Institute of Technology
Massachusetts, United States
Patent: 11
The Salk Institute for Biological Studies
California, United States
Patent: 11
The Johns Hopkins University
North Carolina, United States
Patent: 9
Connecticut, United States
Patent: 8